2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Spinal Cord Neoplasms
1
Neurofibrosarcoma
1
Neurofibroma
1
Nerve Sheath Neoplasms
1
Interventions
Temozolomide
10
Radiotherapy
5
Carboplatin
5
Vincristine
4
Radiosurgery
4
Surveys and Questionnaires
3
Magnetic Resonance Imaging
3
Etoposide
3
Bevacizumab
3
etoposide phosphate
2
Vorinostat
2
Magnetic Resonance Spectroscopy
2
Lomustine
2
Irinotecan
2
Immunoglobulin G
2
Ifosfamide
2
Fluorodeoxyglucose F18
2
Disulfides
2
Cisplatin
2
veliparib
1
tozuleristide
1
romidepsin
1
perillyl alcohol
1
pembrolizumab
1
olutasidenib
1
lonafarnib
1
ispinesib
1
emvododstat
1
cediranib
1
abemaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Spinal Cord Neoplasms
×
Neurofibromin 1
×
Clear all
NCT01567787
2017-02-10
NF01
University of Florida
Phase NA
Withdrawn